Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
32.44
-0.98 (-2.93%)
Mar 27, 2026, 4:00 PM EDT - Market closed
Collegium Pharmaceutical Employees
Collegium Pharmaceutical had 423 employees as of December 31, 2025. The number of employees increased by 66 or 18.49% compared to the previous year.
Employees
423
Change (1Y)
66
Growth (1Y)
18.49%
Revenue / Employee
$1,845,312
Profits / Employee
$148,629
Market Cap
1.03B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 423 | 66 | 18.49% |
| Dec 31, 2024 | 357 | 160 | 81.22% |
| Dec 31, 2023 | 197 | -10 | -4.83% |
| Dec 31, 2022 | 207 | 55 | 36.18% |
| Dec 31, 2021 | 152 | -82 | -35.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Perrigo Company | 8,100 |
| Evotec SE | 4,788 |
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 1,976 |
| Alvotech | 1,012 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
| Harrow | 373 |
COLL News
- 10 days ago - Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript - Seeking Alpha
- 10 days ago - Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory - GlobeNewsWire
- 18 days ago - Collegium Pharmaceutical, Inc. (COLL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 24 days ago - Collegium to Present New Real-World Data at PainConnect 2026 - GlobeNewsWire
- 27 days ago - Collegium to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Collegium Pharmaceutical, Inc. (COLL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Collegium Pharmaceutical: Buying The Projected Growth For 2026 - Seeking Alpha